Harvard Bioscience
HBIO
HBIO
94 hedge funds and large institutions have $142M invested in Harvard Bioscience in 2023 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 40 increasing their positions, 27 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
6% less funds holding
Funds holding: 100 → 94 (-6)
21% less capital invested
Capital invested by funds: $178M → $142M (-$36.6M)
43% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 14
Holders
94
Holding in Top 10
2
Calls
$101K
Puts
$59K
Top Buyers
| 1 | +$1.27M | |
| 2 | +$860K | |
| 3 | +$608K | |
| 4 |
BlackRock
New York
|
+$511K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$500K |
Top Sellers
| 1 | -$1.44M | |
| 2 | -$1.43M | |
| 3 | -$1.13M | |
| 4 |
JF
Jump Financial
Chicago,
Illinois
|
-$336K |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$300K |